Breaking News

inVentiv Health Clinical Names Late-Stage EVP

By Kristin Brooks | February 5, 2014

Okamoto brings management and outcomes research expertise

Lynn Okamoto, Pharm.D., has been named executive vice president of the Late Stage Business Unit at inVentiv Health Clinical, effective March 3rd. Dr. Okamoto has experience as global manager with expertise in healthcare analytics and health outcomes research. She joins the company from Evidera, where she served as senior vice president and senior research scientist of Health Economics & Epidemiology. Previously she led the Intelligent Health Repository at NDC Health.
 
"inVentiv Health was built for this new marketplace, with the broadest range of convergent services in the industry," said Raymond Hill, president inVentiv Health Clinical. "Our Late Stage Clinical group works seamlessly with inVentiv experts in study design and implementation, market access, reimbursement, stakeholder relations and scientific communications to anticipate the questions that will be asked in the marketplace and assure our clients are armed with effective answers."
  • Packaging Equipment Technology Preview

    Packaging Equipment Technology Preview

    February 15, 2017
    Today’s complex drug products present challenges; the latest equipment capabilities help overcome them

  • The Good, the Bad, and the Donald

    The Good, the Bad, and the Donald

    January 31, 2017
    Orphan drugs, CMO continuous manufacturing and developing world sales offer biggest revenue opportunities

  • Predictive Analytics and the Future of RBM

    Rajneesh Patil, Senior Director, RBM and Analytics, QuintilesIMS||January 23, 2017
    How advances in Risk-Based Monitoring will enable a more proactive approach to identify and mitigate potential risks